Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,385,853 papers from all fields of science
Search
Sign In
Create Free Account
Tyrphostins
Known as:
Tyrphostins [Chemical/Ingredient]
, tyrphostin
A family of synthetic protein tyrosine kinase inhibitors. They selectively inhibit receptor autophosphorylation and are used to study receptor…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
38 relations
Narrower (30)
4-nitrobenzylidene malononitrile
6,7-dimethoxy-3-phenylquinoxaline
AG 127
AG 30
Expand
Broader (2)
Antineoplastic Agents
Enzyme Inhibitors
In Blood
agonists
antagonists & inhibitors
aspects of radiation effects
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Regulation of voltage-gated cardiac sodium current by epidermal growth factor receptor kinase in guinea pig ventricular myocytes.
Hui Liu
,
Hai-ying Sun
,
C. Lau
,
Gui-Rong Li
Journal of Molecular and Cellular Cardiology
2007
Corpus ID: 37451084
Highly Cited
2006
Highly Cited
2006
Airway hyper‐responsiveness in allergic asthma in guinea‐pigs is mediated by nerve growth factor via the induction of substance P: a potential role for trkA
A. D. Vries
,
F. Engels
,
+7 authors
Axel Fischer
Clinical and Experimental Allergy
2006
Corpus ID: 23886894
Background: The neurotrophin nerve growth factor (NGF) has been implicated as a mediator in allergic asthma. Direct evidence that…
Expand
Highly Cited
2003
Highly Cited
2003
Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.
S. Kamath
,
J. Buolamwini
Journal of Medicinal Chemistry
2003
Corpus ID: 21786084
The overexpression and/or mutation of the epidermal growth factor receptor family of tyrosine kinases, namely EGFR and HER-2…
Expand
2002
2002
TX-1123: an antitumor 2-hydroxyarylidene-4-cyclopentene-1,3-dione as a protein tyrosine kinase inhibitor having low mitochondrial toxicity.
H. Hori
,
H. Nagasawa
,
+6 authors
Y. Uehara
Bioorganic & Medicinal Chemistry
2002
Corpus ID: 41061204
2001
2001
Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells.
A. Robinson
,
J. Dickenson
European Journal of Pharmacology
2001
Corpus ID: 11492851
Highly Cited
2001
Highly Cited
2001
Regulation of IL-13 production by histamine in cloned murine T helper type 2 cells.
K. Elliott
,
N. Osna
,
M. Scofield
,
M. Khan
International Immunopharmacology
2001
Corpus ID: 8933882
1997
1997
Effect of protein kinase inhibitors on activity of mammalian small heat-shock protein (HSP25) kinase.
K. Hayess
,
R. Benndorf
Biochemical Pharmacology
1997
Corpus ID: 25935633
Highly Cited
1995
Highly Cited
1995
Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase.
Abhijit Mazumder
,
A. Gazit
,
+4 authors
Yves Pommier
Biochemistry
1995
Corpus ID: 25636938
Efficient replication of HIV-1 requires establishment of the proviral state, i.e., the integration of a DNA copy of the viral…
Expand
Highly Cited
1994
Highly Cited
1994
Cytosolic Ca2+ transients are not required for platelet-derived growth factor to induce cell cycle progression of vascular smooth muscle cells in primary culture. Actions of tyrosine kinase.
S. Kobayashi
,
J. Nishimura
,
H. Kanaide
Journal of Biological Chemistry
1994
Corpus ID: 25257328
Highly Cited
1994
Highly Cited
1994
Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemia.
Gurmeet Kaur
,
A. Gazit
,
Alexander Levitzki
,
Emily Stowe
,
David A. Cooney
,
E A Sausville
Anti-Cancer Drugs
1994
Corpus ID: 19639573
We have examined a series of tyrosine kinase inhibitors structurally related to erbstatin (tyrphostins) for inhibition of p210bcr…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE